Sarepta Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
SRPT on Nasdaq
Location
215 First Street, Suite 415, Cambridge, MA

Insiders trading volume in the past year

Sarepta Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard Barry Director $399M Mar 1, 2024
Michael Chambers Director $39.4M +$4.96M +14.4% Aug 16, 2024
Douglas S. Ingram President & CEO, Director $31.4M Nov 3, 2023
M. Kathleen Behrens Director $27.6M Sep 4, 2024
Louise Rodino-Klapac Head of R&D, CSO $6.96M Nov 18, 2024
Ian Estepan Chief Financial Officer $4.66M -$976K -17.3% Aug 30, 2024
Dallan Murray Chief Customer Officer $3.63M -$509K -12.3% Jun 21, 2024
Hans Wigzell Director $2.85M -$3.16M -52.6% Dec 12, 2024
Bilal Arif Chief Tech Ops Officer $2.83M -$2.18M -43.4% Jun 21, 2024
Ryan Brown EVP, General Counsel $2.82M -$6.55M -69.9% Jun 21, 2024
Claude Nicaise Director $2.29M Mar 1, 2024
William Ciambrone Evp $1.78M Mar 4, 2022
Cristin Rothfuss EVP, General Counsel $1.42M Nov 26, 2024
Mary Ann Gray Director $993K Mar 7, 2022
Stephen Mayo Director $814K -$385K -32.1% Mar 5, 2024
Kathryn Boor Director $738K -$299K -28.8% Dec 5, 2024
Deirdre P. Connelly Director $390K Sep 12, 2024

Recent Insider Transactions by Companies or Individuals for Sarepta Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.